Researchers successfully cloned hepatitis B surface antigen (HBsAg)-specific CD8+ and CD4+ T cells. This novel cloning strategy may aid in developing T-cell therapies for hepatitis B infection.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: